PE20040899A1 - Profarmaco inhibidor de beta-lactamasa - Google Patents

Profarmaco inhibidor de beta-lactamasa

Info

Publication number
PE20040899A1
PE20040899A1 PE2003000840A PE2003000840A PE20040899A1 PE 20040899 A1 PE20040899 A1 PE 20040899A1 PE 2003000840 A PE2003000840 A PE 2003000840A PE 2003000840 A PE2003000840 A PE 2003000840A PE 20040899 A1 PE20040899 A1 PE 20040899A1
Authority
PE
Peru
Prior art keywords
hydroximethyl
thia
benzoyloxy
heptane
oxo
Prior art date
Application number
PE2003000840A
Other languages
English (en)
Inventor
Anthony Marfat
Dale Gordon Mcleod
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PE20040899A1 publication Critical patent/PE20040899A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/44Compounds with an amino radical acylated by carboxylic acids, attached in position 6
    • C07D499/48Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE REFIERE A UN PROFARMACO CRISTALINO DE FORMULA I DONDE R ES H O METILO. SON COMPUESTOS PREFERIDOS: ACIDO 4-TIA-1-AZABICICLO[3,2,0]HEPTANO-2-CARBOXILICO,6-(HIDROXIMETIL)-3,3-DIMETIL-7-OXO,-1-(BENZOILOXI)-METIL ESTER, 4,4-DIOXIDO (2S,5R,6R); ACIDO 4-TIA-1-AZABICICLO[3,2,0]HEPTANO-2-CARBOXILICO,6-(HIDROXIMETIL)-3,3-DIMETIL-7-OXO-, -1-(BENZOILOXI)-ETILESTER, 4,4-DIOXIDO (2S,5R,6R) Y ACIDO 4-TIA-1-AZABICICLO[3,2,0]HEPTANO-2-CARBOXILICO,6-(HIDROXIMETIL)-3,3-DIMETIL-7-OXO-, (1R)-1-(BENZOILOXI)ETIL ESTER, 4,4-DIOXIDO (2S,5R,6R); ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA QUE INVOLUCRA A DICHOS COMPUESTOS LOS CUALES SON INHIBIDORES b-LACTAMASA SULFONA DEL ACIDO 6-b-HIDROXIMETILPENICILANICO DE ALTA BIODISPONIBILIDAD ORAL, CON UN PUNTO DE FUSION ADECUADO
PE2003000840A 2002-08-23 2003-08-19 Profarmaco inhibidor de beta-lactamasa PE20040899A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40564002P 2002-08-23 2002-08-23

Publications (1)

Publication Number Publication Date
PE20040899A1 true PE20040899A1 (es) 2004-12-28

Family

ID=31946909

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2003000840A PE20040899A1 (es) 2002-08-23 2003-08-19 Profarmaco inhibidor de beta-lactamasa

Country Status (31)

Country Link
US (1) US7091197B2 (es)
EP (1) EP1534717B1 (es)
JP (1) JP2005539037A (es)
KR (1) KR20050037583A (es)
CN (1) CN1688589A (es)
AP (1) AP2005003231A0 (es)
AR (1) AR041028A1 (es)
AT (1) ATE349452T1 (es)
AU (1) AU2003250489A1 (es)
BR (1) BR0313683A (es)
CA (1) CA2494953A1 (es)
DE (1) DE60310733D1 (es)
EA (1) EA007540B1 (es)
EC (1) ECSP055625A (es)
GT (1) GT200300179A (es)
HR (1) HRP20050162A2 (es)
IL (1) IL166719A0 (es)
IS (1) IS7693A (es)
MA (1) MA27387A1 (es)
MX (1) MXPA05001446A (es)
NO (1) NO20051497L (es)
NZ (1) NZ538340A (es)
OA (1) OA12909A (es)
PA (1) PA8579701A1 (es)
PE (1) PE20040899A1 (es)
PL (1) PL375988A1 (es)
TN (1) TNSN05054A1 (es)
TW (1) TWI250162B (es)
UY (1) UY27947A1 (es)
WO (1) WO2004018484A1 (es)
ZA (1) ZA200501513B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0410936A (pt) * 2003-06-05 2006-06-27 Pfizer Prod Inc pró-fármaco inibidor da beta-lactamase
US20060105941A1 (en) * 2004-11-12 2006-05-18 Allergan, Inc. Mixed antibiotic codrugs
WO2007012319A1 (de) * 2005-07-29 2007-02-01 Sigma-Aldrich Production Gmbh Ionisierungsadditive enthaltende lc/ms-blends
WO2010118968A1 (en) 2009-04-16 2010-10-21 Nicox S.A. No-donor aspirin derivatives
WO2013056163A1 (en) * 2011-10-14 2013-04-18 The Regents Of The University Of California Beta-lactamase inhibitors
CA2860672A1 (en) * 2012-01-06 2013-07-11 University Of South Florida Compositions, methods of use, and methods of treatment
CN109422765B (zh) * 2017-09-05 2020-08-28 香港理工大学深圳研究院 C类β-内酰胺酶抑制剂及其制备方法和应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE34011B1 (en) 1969-03-13 1975-01-08 Leo Pharm Prod Ltd New penicillin esters
IE34019B1 (en) 1969-03-18 1975-01-08 Leo Pharm Prod Ltd New semi-synthetic penicillin esters
GB1267936A (en) 1969-05-28 1972-03-22 Beecham Group Ltd DERIVATIVES OF alpha-AMINOPENICILLINS
US3957764A (en) 1969-11-11 1976-05-18 Lovens Kemiske Fabrik Produktionsaktieselskab 6-aminopenicillanic acid derivatives
US3862181A (en) 1970-10-28 1975-01-21 Squibb & Sons Inc Process for preparing cephalosporins
GB1315566A (en) 1970-11-06 1973-05-02 Leo Pharm Prod Ltd Penicillanic acid derivatives
CA996929A (en) 1971-04-05 1976-09-14 Kohzi Nakano Acyloxyalkyl ester derivatives of penicillin
GB1433131A (en) 1972-03-13 1976-04-22 Astra Laekemedel Ab Penicillins
GB1426717A (en) 1972-03-13 1976-03-03 Astra Laekemedel Ab Penicillins
US4397783A (en) 1979-03-05 1983-08-09 Pfizer Inc. Process for converting 6,6-disubstituted penicillanic acid derivatives to the 6-β-congeners
DE2927004A1 (de) * 1979-07-04 1981-05-27 Bayer Ag, 5090 Leverkusen Penicillansaeure-1,1-dioxide, ihre herstellung und ihre verwendung als arzneimittel als arzneimittel
US4287181A (en) * 1979-10-22 1981-09-01 Pfizer Inc. Derivatives of 6β-hydroxyalkylpenicillanic acids as β-lactamase inhibitors
US4432970A (en) 1979-11-23 1984-02-21 Pfizer Inc. 6-beta-Halopenicillanic acid 1,1-dioxides as beta-lactamase inhibitors
GB2076812A (en) * 1980-05-22 1981-12-09 Ciba Geigy Ag Penam-dioxide compounds, processes for their manufacture, and their use
JPS5849387A (ja) 1981-09-17 1983-03-23 Sankyo Co Ltd 7−メトキシセフアロスポリン化合物およびその製法
AU559689B2 (en) * 1981-09-22 1987-03-19 Kureha Kagaku Kogyo K.K. Penicillin derivative
US4406887A (en) 1981-10-13 1983-09-27 Bristol-Myers Company Method for treating resistant bacteria including anaerobes
US4428935A (en) * 1982-05-24 1984-01-31 Pfizer Inc. Penicillanic acid dioxide prodrug
US4521533A (en) 1984-07-12 1985-06-04 Pfizer Inc. Salts of 6-alpha-(aminomethyl)penicillanic acid 1,1-dioxide esters and beta-lactam antibiotics
DE3901405A1 (de) 1989-01-19 1990-07-26 Hoechst Ag Cephalosporinderivate und verfahren zu ihrer herstellung
JPH03206038A (ja) 1990-01-08 1991-09-09 Yoshitomi Pharmaceut Ind Ltd 抗菌剤
GB9001405D0 (en) 1990-01-22 1990-03-21 Leo Pharm Prod Ltd New intermediates,their production and use
GB9208492D0 (en) 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
BRPI0410936A (pt) 2003-06-05 2006-06-27 Pfizer Prod Inc pró-fármaco inibidor da beta-lactamase

Also Published As

Publication number Publication date
MA27387A1 (fr) 2005-06-01
TW200417548A (en) 2004-09-16
US7091197B2 (en) 2006-08-15
IS7693A (is) 2005-02-10
EA200500398A1 (ru) 2005-08-25
NO20051497D0 (no) 2005-03-21
EP1534717A1 (en) 2005-06-01
US20040110740A1 (en) 2004-06-10
HRP20050162A2 (en) 2005-06-30
WO2004018484A1 (en) 2004-03-04
AP2005003231A0 (en) 2005-03-31
KR20050037583A (ko) 2005-04-22
EP1534717B1 (en) 2006-12-27
ZA200501513B (en) 2006-09-27
JP2005539037A (ja) 2005-12-22
MXPA05001446A (es) 2005-06-06
CN1688589A (zh) 2005-10-26
ATE349452T1 (de) 2007-01-15
ECSP055625A (es) 2005-04-18
TNSN05054A1 (fr) 2007-05-14
GT200300179A (es) 2004-05-18
NZ538340A (en) 2006-10-27
AU2003250489A1 (en) 2004-03-11
UY27947A1 (es) 2004-03-31
CA2494953A1 (en) 2004-03-04
NO20051497L (no) 2005-03-21
DE60310733D1 (de) 2007-02-08
EA007540B1 (ru) 2006-10-27
OA12909A (en) 2006-10-13
PL375988A1 (en) 2005-12-12
PA8579701A1 (es) 2005-05-24
TWI250162B (en) 2006-03-01
BR0313683A (pt) 2005-06-21
IL166719A0 (en) 2006-01-15
AR041028A1 (es) 2005-04-27

Similar Documents

Publication Publication Date Title
EA200500312A1 (ru) Новые спироконденсированные хиназолиноны и их применение в качестве ингибиторов фосфодиэстераз
UY28897A1 (es) Ácido 2-((2-(2-metilaminopirimidin-4-il)-1h-indol-5-carbonil)amino)-3-(fenilpiridin-2-ilamino)propiónico sustancialmente puro como inhibidor de la cinasa ikb
ATE377420T1 (de) Phenylalkansäure- und phenyloxyalkansäure- derivate als hppar aktivatore
DK1569899T3 (da) Substituerede 3-alkyl- og 3-arylalkyl-1H-indol-1-yl-eddikesyrederivater som inhibitorer af plasminogenaktivator-inhibitor-1 (PAI-1)
EA200500299A1 (ru) Пиразольные композиции, используемые в качестве ингибиторов gsk-3
EA200400073A1 (ru) Пирролопиримидины как ингибиторы протеинкиназы
PE20040897A1 (es) 8-[3-amino-piperidin-1-il]-xantinas y su preparacion como medicamentos
DK1585739T3 (da) Substituerede arylcyclopropylacetamider som glucokinaseaktivatorer
WO2004037181A3 (en) Glycinenitrile-based inhibitors of dipeptidyl peptidase iv and methods
DK1663206T3 (da) 1-(2,3-dimethyl-phenyl)-ethyl-1,3-dihydro-imizadol-2-thion som ikke-sedativ alpha 2A-agonist
EA200400480A1 (ru) N-замещённые производные пирролидина в качестве ингибиторов дипептидилпептидазы
DK0705254T3 (da) Phenylheterocykliske forbindelser som cyclooxygenase-2-inhibitorer
CY1107473T1 (el) Ενα παραγωγο pyridine-n-oxide, και διαδικασια για τη μετατροπη του σε αποτελεσματικες φαρμακευτικες συνθεσεις
EA200600594A1 (ru) Новые гетероциклические соединения - ингибиторы hsp90 и способы их получения
EA200201179A1 (ru) Производные 2-аминокарбонил-9h-пурина
SE0202463D0 (sv) Novel compounds
PE20050012A1 (es) Compuestos de benzopirano como inhibidores de la ciclooxigenasa-2
CL2008003324A1 (es) Formulacion farmaceutica liquida de liberacion inmediata que comprende una sal de adicion de acido de un compuesto derivado de azetidina sustituido y un diluyente o portador farmaceuticamente aceptable, util para el tratamiento o prevencion de trombosis.
BRPI0617655A2 (pt) composto ou um sal farmaceuticamente aceitável do mesmo, ou um isômero óptico do mesmo, uso de um composto, e, formulação farmacêutica
EA200200510A1 (ru) 4-карбоксиамино-2-этил-1,2,3,4-тетрагидрохинолин в кристаллической форме как ингибитор сетр
HN2003000044A (es) Esteres hidroxamato del acido n - (4-fenil sustituido)-antranilico.
AR051797A1 (es) Derivados de hidantoina inhibidores de metaloproteinasas
DOP2009000106A (es) Compuestos de pirazol y triazol sustituídos como inhibidores de ksp
UY27618A1 (es) Ésteres hidroxamato de ácido n-(4-fenil-sustituido)-antranílico
EA200400708A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed